a-chain variable region 14-a-chain joining region 18 (V a 14J a 18) T cell antigen receptor (TCR) a-chain. The i NKT cells derive from CD4 + CD8 + double-positive (DP) thymocytes, and their generation requires a long half-life of DP thymocytes to allow V a 14-J a 18 rearrangements, expression of glycolipid-loaded CD1d on DP thymocytes, and signaling through the signaling-activation molecule SLAM-adaptor SAP pathway. Here we show that the transcription factor c-Myb has a central role in priming DP thymocytes to enter the i NKT lineage by simultaneously regulating CD1d expression, the half-life of DP cells and expression of SLAMF1, SLAMF6 and SAP.
A r t i c l e s Invariant natural killer T cells (iNKT cells) are a subset of αβ T cells characterized by the expression of an invariant α-chain variable region 14-α-chain joining region 18 (V α 14J α 18) T cell antigen receptor (TCR; V α 24J α 18 in humans) in combination with certain TCRβ chains (V β 8.2, V β 7 or V β 2 in mice, or V β 11 in humans). The iNKT cells in mice can be CD4 + or double negative (DN; CD4 − CD8 − ), generally have a memory or activated phenotype (CD69 + CD62L − CD44 hi IL-2R hi ) and express markers characteristic of NK cells, including NK1.1, NKG2D and Ly49. They are found mainly in the liver and bone marrow but also in the thymus, spleen and blood. The iNKT cells develop in the thymus from the same precursors as conventional CD4 + and CD8 + αβ T cells: CD4 + CD8 + double-positive (DP) thymocytes 1 . In contrast to conventional αβ T cells, which are selected by complexes of peptide and major histocompatibility complex presented by thymic epithelial cells, iNKT cells are selected by lipid antigens presented by the nonpolymorphic, major histocompatibility complex class I-like molecule CD1d, present on the surface of other DP thymocytes [2] [3] [4] [5] . An absolute prerequisite for the generation of iNKT cells is stochastic rearrangement of the invariant V α 14J α 18 TCRα chain. Given the orderly sequence of rearrangements in the TCRα locus (proximal to distal) and the distal position of J α 18 in the J α region, V α 14-J α 18 rearrangements are always secondary 6 . Therefore, an extended lifespan of DP cells is necessary for the development of iNKT cells, as shown by the defects in iNKT cell development in mice deficient in the transcription factor RORγt and the Bcl-x L survival factor [7] [8] [9] . A third prerequisite for iNKT selection is the cooperative engagement of the TCR and two members of the signaling lymphocytic-activation molecule (SLAM) family (SLAMF1 and SLAMF6) 10 . SLAM engagement recruits the adaptor SAP and the Src kinase Fyn, both of which are essential for the selection of the iNKT cell lineage [11] [12] [13] [14] [15] .
Once they are positively selected, iNKT cells undergo a process of differentiation and population expansion that results in the acquisition of their activated NK cell-like phenotype. The differentiation of iNKT cells in the thymus occurs through stages characterized by certain phenotypic markers and sensitivity to various mutations 2, 5, 16 . Once a DP thymocyte expresses the invariant TCR and receives signals through SLAM-SAP and the TCR (control point 1), it begins to downregulate the cell surface marker CD24 (heat-stable antigen (HSA)) and upregulate first the activation and memory marker CD44 and later the NK cell marker DX5. These cells are small, NK1.1 − and not cycling. Some of these cells can exit the thymus and mature into NK1.1 + iNKT cells in the periphery, whereas others continue to differentiate in the thymus. The transition of iNKT cells from NK1.1 − to NK1.1 + is accompanied by a proliferative burst (control point 2). Molecules important for iNKT cell differentiation include costimulatory molecules such as CD28 (ref. 17); signal-transduction components such as Itk, Rlk, NF-κB and PKC-θ 18 ; cytokines such as interleukin 19 ; and transcription factors such as PLZF 20, 21 , T-bet 22 , GATA-3 (ref. 23 ) and c-Myc 24 .
The transcription factor c-Myb is expressed in hematopoietic stem cells and progenitors of all hematopoietic lineages and is required for definitive hematopoiesis 25 . Progression through hematopoiesis requires distinct c-Myb expression thresholds 26, 27 . In the thymus, the CD4 − CD8 − DN and CD4 + CD8 + DP thymocyte subsets have the highest expression of c-Myb, and its expression decreases after positive selection 28, 29 . Chimeric mice deficient in both c-Myb and recombinationactivating gene 1 have a block at the CD44 lo CD25 − DN stage of development, which proves that c-Myb is required for early T cell development 30 . Dominant interfering c-Myb blocks β-selection 31 , whereas conditional deletion of c-Myb at various stages of T cell development has suggested that c-Myb influences the DN-to-DP transition, the survival of DP thymocytes and the differentiation of CD4 + single-positive (SP) thymocytes 28 . Along with published evidence 32, 33 , these experiments suggested that c-Myb may be involved in the recombination A r t i c l e s of TCRα, TCRβ and TCRδ. In addition, c-Myb is important for GATA-3 upregulation during commitment to the CD4 lineage 29 . Notably, GATA-3 seems to have a role in controlling the survival and functional maturation of iNKT cells 23 . Given the described role of c-Myb in regulating the recombination of TCRβ, TCRδ and TCRα 28, 32, 33 and the role of GATA-3 in the functional maturation and survival iNKT cells 23 , we hypothesized that c-Myb could be involved in the development and/or function of iNKT cells. Our results show that c-Myb has a central role in priming DP thymocytes to enter the iNKT lineage by simultaneously regulating CD1d expression, the half-life of DP cells and expression of SLAMF1, SLAMF6 and SAP.
RESULTS

The generation of iNKT cells requires c-Myb
To analyze the effect of c-Myb deficiency during positive selection and avoid the confounding effects of early deletion, we crossed mice with two loxP-flanked alleles encoding c-Myb (Myb f/f ) 28 with mice in which expression of Cre recombinase is driven by the promoter of the mouse gene encoding CD4 (Cd4-Cre) to delete c-Myb at the DP stage of T cell development. We then compared the phenotypes of Myb f/f Cd4-Cre (c-Myb-deficient) mice and Gata3 f/f Cd4-Cre (GATA-3deficient) mice. As reported before for Myb f/f Lck-Cre mice, c-Mybdeficient thymocytes had a moderate defect in the generation of mature CD4 + SP cells (Fig. 1a) . The effect was less pronounced than that of Gata3 f/f Cd4-Cre mice, which suggested that additional regulators besides c-Myb contribute to the upregulation of GATA-3 during commitment to the CD4 lineage. Using Cd1d tetramers loaded with the α-galactosylceramide analog PBS57 (ref. 34) , we observed that in contrast to Gata3 f/f Cd4-Cre mice, which have normal numbers of thymic iNKT cells but fewer spleen and liver iNKT cells 23 , Myb f/f Cd4-Cre mice showed a complete absence of iNKT cells in the thymus, spleen and liver ( Fig. 1a) . Even after enrichment of tetramer-binding cells in the thymus 35 we were unable to detect any tetramer-binding precursors in the thymus of Myb f/f Cd4-Cre mice ( Fig. 1b) , including HSA hi cells (stage 0), which have not yet received positive selection signals. These results indicate that c-Myb is absolutely required for the development of iNKT cells, in addition to regulating GATA-3.
The defect in iNKT cell development is cell intrinsic
The iNKT cells are selected by interactions between DP thymocytes and DP thymocytes through TCR recognition of CD1d-glycolipid complexes. Because we observed lower expression of CD1d in Myb f/f Cd4-Cre DP thymocytes ( Supplementary Fig. 1 ), we tested whether the iNKT cell developmental defect in Myb f/f Cd4-Cre mice could be 'rescued' by the presence of DP thymocytes with normal expression of CD1d. We reconstituted lethally irradiated CD45.1 + wild-type hosts with a 1:1 mixture of bone marrow cells from Myb f/f Cd4-Cre (CD45.2 + ) mice and F 1 C57BL/6 (CD45.1 + CD45.2 + ) mice ( Fig. 2a) . We analyzed chimeras 8-12 weeks later to determine whether Myb f/f Cd4-Cre DP thymocytes could develop into iNKT cells in the presence of normal DP thymocytes. In these conditions, Myb f/f Cd4-Cre thymocytes generated normal numbers of CD8 + SP cells and, as expected, fewer CD4 + SP thymocytes ( Fig. 2b) . However, wild-type DP thymocytes did not restore the generation of iNKT cells from Myb f/f Cd4-Cre progenitors ( Fig. 2c) , which suggested that the defect in CD1d expression was not sufficient to explain the iNKT cell phenotype of Myb f/f Cd4-Cre mice. 
A r t i c l e s
Defective TCRa rearrangements in c-Myb-deficient DP thymocytes
Because c-Myb has been linked to the regulation of recombination at the TCRαδ locus, we used a semiquantitative PCR-based assay 9 for mature V α transcripts to assess TCRα locus rearrangements in thymocytes from Myb f/f Cd4-Cre mice, wild-type C57BL/6 and CD1ddeficient mice. To assess V α rearrangements before positive selection, we used sorted DP thymocytes (CD4 + CD8 + TCR int CD69 − ) for this assay. Rearrangement in the V α locus proceeds in an orderly way, with proximal V α and J α recombining first. Therefore, we tested the use of a proximal V α segment (AV6), central V α segments (AV3, AV8 and AV14) and a distal V α segment (AV19) in Myb f/f Cd4-Cre, wild-type and CD1d-deficient thymocytes with AV family-based primers for AV3 and AV8. There were considerably fewer distal V α transcripts (AV19) in the Myb f/f Cd4-Cre samples, whereas the use of proximal (AV6) V α transcripts and central (AV8, AV14 and AV3) V α transcripts was similar in DP thymocytes from C57BL/6, CD1d-deficient and Myb f/f Cd4-Cre mice ( Fig. 3a,b) . These results suggested that Myb f/f Cd4-Cre thymocytes have a defect in the use of distal V α segments.
To characterize J α use, we used family-based primers for the AV3 and AV8 families and primers for J α segments in the proximal (J α 50), central (J α 30) and distal (J α 18 and J α 2) regions of the J α locus 7 . We also analyzed the V α 14-J α 18 rearrangement characteristic of the iNKT cell TCR. DP thymocytes from Myb f/f Cd4-Cre mice had normal amounts of transcripts from every V α segment to the proximal J α 50 segment (V α 3J α 50 and V α 8J α 50; Fig. 3a,c) . Rearrangements to J α 30 (V α 3J α 30 and V α 8J α 30) were slightly decreased, whereas we did not detect rearrangements to the most distal J α 2 segment (V α 3J α 2 and V α 8J α 2).
Myb f/f Cd4-Cre DP thymocytes had fewer V α 3-J α 18, V α 8-J α 18 and V α 14-J α 18 rearrangements ( Fig. 3a,c,d ). This shows that Myb f/f Cd4-Cre thymocytes have a defect in distal J α segment rearrangements and as a consequence cannot efficiently generate the V α 14-J α 18 rearrangements characteristic of the TCR required for iNKT cell generation.
Bcl-x L corrects the DP survival defect of c-Myb-deficient mice
The observed defect in secondary TCRα rearrangements could have been due to a direct effect of c-Myb deficiency on V α rearrangement or an indirect effect on the survival of DP thymocytes. A similar phenotype has been reported for RORγt-deficient mice and Bcl-x L -deficient mice due to the shorter half-life of DP thymocytes in these mice [7] [8] [9] . Because DP thymocytes from Myb f/f Lck-Cre mice have lower survival 28 , we analyzed whether defects in survival and/or the expression of RORγt and Bcl-x L caused the defect in our Myb f/f Cd4-Cre model.
We used quantitative RT-PCR to analyzed the expression of survival factors (Bcl-x L , RORγt, Bcl-2 and Mcl-1) in sorted DP thymocytes from Myb f/f Cd4-Cre and Myb f/f mice. With the exception of Bcl-x L , which showed 50% less expression, the expression of these survival factors was not altered much in Myb f/f Cd4-Cre DP thymocytes (Fig. 4a) . The Bcl-x L expression defect was consistent with the competitive disadvantage of c-Myb-deficient cells in the mixed-bone marrow chimera described above. In the wild-type-Myb f/f Cd4-Cre chimeras, we observed no significant differences between wild-type and Myb f/f Cd4-Cre donors at the DN level (before c-Myb has been lost), whereas Myb f/f Cd4-Cre DP thymocytes were underrepresented ( Fig. 4b) , consistent with the reported role of c-Myb in regulating the survival of DP cells 28 . We did (2)) with five mice per experiment. (Fig. 5a) . Overexpression of Bcl-x L did not restore the development of iNKT cells from Myb f/f Cd4-Cre DP thymocytes (Fig. 5b) , although the virus induced high expression of Bcl-x L in Myb f/f Cd4-Cre DP thymocytes (Fig. 5c) . The Bcl-x L transgene was functional, as its expression improved the ability of Myb f/f Cd4-Cre cells to compete with wild-type thymocytes in the DP compartment ( Fig. 5d ) and resulted in a higher percentage of CD8 + SP thymocytes, as described before 36 . In similar experiments, overexpression of RORγt, an upstream regulator of Bcl-x L , also failed to restore the development of iNKT cells from Myb f/f Cd4-Cre thymocytes (Supplementary Fig. 2) . These data demonstrate that correcting the survival defect of Myb f/f Cd4-Cre thymocytes was not sufficient to restore iNKT cell development.
To further address whether the defect in secondary TCRα rearrangements in Myb f/f Cd4-Cre thymocytes was due exclusively to survival or was due to a direct effect of c-Myb on rearrangement, we sorted wild-type, Myb f/f Cd4-Cre GFP + and Myb f/f Cd4-Cre GFP − DP thymocytes from the bone marrow chimeras and analyzed rearrangements across the TCRα locus as described above. Myb f/f Cd4-Cre DP thymocytes expressing Bcl-x L had detectable distal TCRα rearrangements, including V α 14-J α 18 (Fig. 5e,f) . This suggested that the restoration of survival was sufficient to restore normal secondary rearrangements. These experiments demonstrate that c-Myb regulates the survival of DP thymocytes and that restoring the survival of DP thymocytes by forced expression of Bcl-x L restored secondary TCRα rearrangements. However, this was not sufficient to restore iNKT cell development, which suggests that c-Myb controls additional pathways required in this process.
Partial restoration by a rearranged TCRa chain
To directly assess whether a lack of V α 14-J α 18 rearrangements was the only defect in Myb f/f Cd4-Cre thymocytes, we bred Myb f/f Cd4-Cre mice with transgenic mice expressing a rearranged V α 14J α 18 TCRα chain under control of the Cd4 promoter 10 . V α 14J α 18 + mice had a higher percentage of tetramer-reactive cells in the thymus than did wild-type mice, and these iNKT cells included a higher percentage of HSA hi and NK1.1 − cells, both CD4 + and DN, probably because many more iNKT cells were undergoing positive selection ( Supplementary  Fig. 3 ). V α 14J α 18 + Myb f/f Cd4-Cre (V α 14-transgenic c-Myb-deficient) mice had a lower percentages and absolute number of iNKT cells in the thymus, spleen and liver than did V α 14J α 18 + Myb +/f Cd4-Cre (V α 14-transgenic c-Myb-sufficient) mice (Fig. 6a,b) . V α 14-transgenic c-Myb-deficient mice had a lower percentage and number of the most mature thymic iNKT cell populations, CD44 + NK1.1 + iNKT cells and HSA lo iNKT cells, than did V α 14-transgenic c-Myb-sufficient mice (Fig. 6c) , which suggested that positive selection and intrathymic maturation of DP thymocytes bearing a PBS57-CD1d tetramer-reactive TCR is impaired in the absence of c-Myb.
To test whether the PBS57-CD1d tetramer-positive cells generated in V α 14J α 18 + Myb f/f Cd4-Cre mice acted like iNKT cells, we stimulated thymocytes in vitro for 4 h with the phorbol ester PMA and ionomycin in the presence of monensin and assessed production of the cytokines IL-4 and interferon-γ (IFN-γ) by intracellular staining. PBS57-CD1d tetramer-positive thymocytes from V α 14J α 18 + Myb f/f Cd4-Cre and V α 14J α 18 + Myb +/f Cd4-Cre mice acted like wild-type iNKT cells (Fig. 6d) , with a high percentage of cells able to produce IL-4 and IFN-γ simultaneously after a short stimulation. This suggests that c-Myb-deficient cells that can go through positive selection develop into apparently normal iNKT cells. These results suggest that c-Myb has additional roles in iNKT cell development, as not even expression of a CD1d-reactive TCR in many DP thymocytes was able to restore the normal development of iNKT cells in the absence of c-Myb. Furthermore, the phenotype of the iNKT cells generated, with an accumulation of more immature phenotypes, including HSA hi and NK1.1 − , suggested that the defect may be in early stages of positive selection of the iNKT lineage.
Expression of SLAMs in c-Myb-deficient DP thymocytes
In addition to the signals mediated by the TCR-CD1d interaction, the development of iNKT cells requires signals initiated by homophilic interactions between members of the SLAM family, mainly SLAMF1 and SLAMF6 (ref. 10) , and mediated by the adaptor SAP [11] [12] [13] [14] [15] . Given the partial blockade in the positive selection of DP thymocytes bearing a tetramer-reactive TCR in Myb f/f Cd4-Cre mice, we analyzed the expression of these proteins in Myb f/f Cd4-Cre DP thymocytes. Quantitative RT-PCR analysis of sorted DP thymocytes showed lower expression of SLAMF1, SLAMF6 and SAP mRNA in cells from Myb f/f Cd4-Cre mice than in those from Myb +/f Cd4-Cre mice (Fig. 7a) . As noted above, RORγt expression was not altered (data not shown). The surface expression of SLAMF1 and SLAMF6 was lower in DP thymocytes from Myb f/f Cd4-Cre mice than in those from Myb +/f Cd4-Cre mice (Fig. 7b) . This was evident only at the DP stage, and expression of other SLAMF family members, such as SLAMF3 and SLAMF5, was not affected. In addition, expression of SAP, as assessed by intracellular staining, was lower in DP thymocytes from Myb f/f Cd4-Cre mice. These results suggest that the expression of SLAM and SAP was impaired in Myb f/f Cd4-Cre DP thymocytes and this could explain the positive selection defect observed in the V α 14J α 18 + Myb f/f Cd4-Cre mice.
Defective SLAM-SAP signals in c-Myb-deficient DP thymocytes
To assess whether signaling through the SLAM-SAP axis was impaired in Myb f/f Cd4-Cre DP thymocytes, we set up mixed-bone marrow chimeras in which we used DP thymocytes from Myb f/f Cd4-Cre mice or J α 18-deficient mice 37 as 'helpers' for the iNKT cell differentiation of CD1d-deficient DP thymocytes (Supplementary Fig. 4) . We reconstituted lethally irradiated wild-type (CD45.1 + ) hosts with a mixture of bone marrow cells from CD1d-deficient (CD45.2 + CD1d − ) mice and Myb f/f Cd4-Cre or J α 18-deficient (CD45.2 + CD1d + ) mice (Fig. 8a) . Given the competitive defect of Myb f/f Cd4-Cre DP thymocytes in this experimental setup (Fig. 4b) , we used an excess (Fig. 8b) . To ensure that host DP thymocytes did not contribute to the iNKT cell selection process, we excluded chimeras with a substantial host contribution. J α 18-deficient thymocytes can supported the development of CD1d-deficient iNKT cells, which migrated to the liver, whereas Myb f/f Cd4-Cre thymocytes were unable to do so (Fig. 8a,c) . These results show that the defect in the expression of SLAM and CD1d in Myb f/f Cd4-Cre thymocytes contributed to the block in iNKT cell generation observed in these mice.
DISCUSSION
The development of iNKT cells has at least three basic prerequisites: productive rearrangement of a V α 14J α 18 TCR, expression of glycolipid-loaded CD1d, and signaling through the SLAM-SAP pathway. Furthermore, for productive rearrangement of V α 14J α 18, DP thymocytes need a minimum lifespan, because the α-chain is always generated as a result of secondary V α rearrangements. Here we have provided evidence that c-Myb is critical for the fulfillment of each of these prerequisites. Myb f/f Cd4-Cre DP thymocytes had lower expression of Bcl-x L , which resulted in a shorter lifespan and, consequently, a lack of secondary TCRα rearrangements, and lower expression of CD1d and several critical molecules of the SLAM-SAP signaling pathway. As a result of these defects, no iNKT cell precursors were generated.
Although c-Myb does not absolutely control any of the prerequisites for iNKT cell development, it positively regulates each of them, allowing DP thymocytes to live long enough to rearrange the canonical V α 14J α 18 TCR and to have sufficiently high expression of CD1d and molecules of the SLAM-SAP signaling pathway to generate the signals that enable iNKT cell positive selection. Deficiency in c-Myb led to alterations in Bcl-x L expression; however, this effect was independent of expression of RORγt and the transcription factors TcF and Lef (data not shown), two factors that have been described as controlling Bcl-x L expression 38, 39 . This survival defect seemed to be the main cause of the defective rearrangement of distal V α J α segments in Myb f/f Cd4-Cre thymocytes, although more detailed analysis is needed to completely discard the possibility of a direct effect of c-Myb on TCRα rearrangement, especially given its described role in rearrangement of the βand δ-loci 28, 32, 33 .
Although Bcl-x L was able to restore the survival of Myb f/f Cd4-Cre DP thymocytes and TCRα rearrangement, we still observed a complete block in iNKT cell development. Partial restoration, in terms of the number and maturation status of the iNKT cells, also occurred after expression of a prerearranged TCRα. This was probably due to independent defects in the expression of SLAMF1, SLAMF6 and SAP. The effect of c-Myb on the expression of SLAMF1 and SLAMF6 in DP thymocytes is very selective, as other family members located in the same genomic locus (SLAMF2, SLAMF3 and SLAMF5) are not affected. These observations may have important implications, because the SLAM locus has been identified as a susceptibility locus in several mouse autoimmunity models, including systemic lupus erythematosus (the Sle1b allele) 40 and nonobese diabetes (the Nktcn1 allele) 41 . The Nktcn1 allele is responsible for the lower number of NKT cells in the nonobese diabetic mouse strain 42 and, notably, the expression pattern of SLAM family members is similarly altered in the thymi of mice carrying the Nktcn1 allele and in Myb f/f Cd4-Cre mice 41 . This suggests that the polymorphisms that determine the altered SLAM expression in mice with the Nktcn1 allele may alter c-Myb function. Whether this is a direct effect due to the binding of c-Myb to regulatory elements that control the expression of SLAM family members remains to be determined. Our work has shown how a series of relatively small changes in the expression of various molecules orchestrated by c-Myb completely determines the existence of a critical lineage of cells of the immune response. Given the important role of iNKT cells in the responses to many diseases and the wide variability in iNKT cell numbers in human populations 43 , polymorphisms in c-Myb or in some of its binding sites may have an important role in susceptibility to disease.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
